Divi's Lab.

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,760.55",
    "chg": 86.35,
    "chgp": "1.29%",
    "dir": 1,
    "prev_price": "6,674.20",
    "mcapval": "180,134.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "Jul 03, 03:30 PM",
    "curr_time": "16:49 PM",
    "last_traded_at": "Jul 03, 03:30 PM IST",
    "bse_nse_vol": "3.99 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 03, 2026",
    "traded_date_str": "2026 07 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4086870",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_technicaldot_4086870.png",
        "date": "2026-07-03 08:02:24",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling renewed investor interest and potential upside in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-significant-open-interest-surge-amid-mixed-price-action-4081958",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_oi_spurts_by_underlying_4081958.png",
        "date": "2026-07-01 15:00:19",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 11.2% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal price decline of 0.36% on 1 Jul 2026, the underlying shifts in volume and OI suggest nuanced directional bets and increased investor participation."
      },
      {
        "title": "Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-significant-open-interest-surge-amid-mixed-price-action-4081895",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_oi_spurts_by_underlying_4081895.png",
        "date": "2026-07-01 14:00:16",
        "description": "Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.8% increase in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the surge in open interest alongside rising delivery volumes suggests a complex interplay of directional bets and liquidity dynamics."
      },
      {
        "title": "Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-significant-open-interest-surge-amid-mixed-market-signals-4081827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_oi_spurts_by_underlying_4081827.png",
        "date": "2026-07-01 13:00:19",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.2% surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning despite a marginal decline in its share price. This development comes amid mixed technical indicators and a cautious market environment, prompting a closer examination of the underlying factors driving this sudden spike in open interest and its implications for directional bets."
      },
      {
        "title": "Divis Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4078144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_mojoScore_4078144.png",
        "date": "2026-06-30 08:17:13",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 29 June 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite strong fundamentals and consistent quarterly performance, evolving market dynamics and technical signals have prompted a more cautious stance among analysts."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-4077823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_technicaldot_4077823.png",
        "date": "2026-06-30 08:03:41",
        "description": "Divis Laboratories Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late June 2026. Despite a recent decline in share price, the pharmaceutical giant's technical indicators present a nuanced picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the latest technical parameters, market context, and comparative returns to provide a comprehensive view for investors."
      },
      {
        "title": "54,163 Put Contracts on Divis Laboratories Ltd at Rs 6,500 Strike Ahead of June Expiry",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-heavy-put-option-activity-amid-bearish-sentiment-4076666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_most_active_stocks_puts_4076666.png",
        "date": "2026-06-29 10:00:10",
        "description": "Rs 6,500 put options on Divis Laboratories Ltd attracted 54,163 contracts on 29 Jun 2026, signalling significant activity just one day before the 30 June expiry. The stock trades at Rs 6,656.50, placing these puts approximately 2.3% out-of-the-money, which suggests a nuanced interpretation beyond outright bearishness."
      },
      {
        "title": "Divis Laboratories Sees 0.45% Dip Amid Strong Technical Upgrade and Derivatives Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-045-dip-amid-strong-technical-upgrade-and-derivatives-surge-4075558",
        "imagepath": "",
        "date": "2026-06-27 17:03:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>22 Jun:</strong> Upgrade to Buy rating by MarketsMOJO</p>\n                    <p><strong>23 Jun:</strong> Stock price nears 52-week high at ₹6,784.95</p>\n                    <p><strong>25 Jun:</strong> Sharp 14.1% surge in open interest amid price decline</p>\n                    <p><strong>26 Jun:</strong> Week closes at ₹6,710.85 (-0.45%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,741.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.6,710.85</div><div class=\"stat-change n..."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-price-action-4073563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_oi_spurts_by_underlying_4073563.png",
        "date": "2026-06-25 15:00:35",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 14.1% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price decline of 0.62% on 25 Jun 2026, the stock’s derivatives market reveals a complex interplay of directional bets and liquidity dynamics that merit close attention from investors and analysts alike."
      }
    ],
    "total": 664,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Jun-2026",
      "details": "Intimation of closure of Trading Window from July 01 2026.",
      "source": "BSE"
    },
    {
      "caption": "Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2025-26",
      "datetime": "11-Jun-2026",
      "details": "As per enclosed letter.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Jun-2026",
      "details": "Copies of Newspaper Publication - Notice to the shareholders regarding transfer of unclaimed dividends and equity shares to IEPF",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-07-03 08:02:24

Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling renewed investor interest and potential upside in the Pharmaceuticals & Biotechnology sector.

Read full news article

Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Price Action

2026-07-01 15:00:19

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 11.2% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal price decline of 0.36% on 1 Jul 2026, the underlying shifts in volume and OI suggest nuanced directional bets and increased investor participation.

Read full news article

Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Price Action

2026-07-01 14:00:16

Divis Laboratories Ltd, a large-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.8% increase in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the surge in open interest alongside rising delivery volumes suggests a complex interplay of directional bets and liquidity dynamics.

Read full news article

Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-07-01 13:00:19

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.2% surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning despite a marginal decline in its share price. This development comes amid mixed technical indicators and a cautious market environment, prompting a closer examination of the underlying factors driving this sudden spike in open interest and its implications for directional bets.

Read full news article

Divis Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-06-30 08:17:13

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 29 June 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite strong fundamentals and consistent quarterly performance, evolving market dynamics and technical signals have prompted a more cautious stance among analysts.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-30 08:03:41

Divis Laboratories Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late June 2026. Despite a recent decline in share price, the pharmaceutical giant's technical indicators present a nuanced picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the latest technical parameters, market context, and comparative returns to provide a comprehensive view for investors.

Read full news article

54,163 Put Contracts on Divis Laboratories Ltd at Rs 6,500 Strike Ahead of June Expiry

2026-06-29 10:00:10

Rs 6,500 put options on Divis Laboratories Ltd attracted 54,163 contracts on 29 Jun 2026, signalling significant activity just one day before the 30 June expiry. The stock trades at Rs 6,656.50, placing these puts approximately 2.3% out-of-the-money, which suggests a nuanced interpretation beyond outright bearishness.

Read full news article

Divis Laboratories Sees 0.45% Dip Amid Strong Technical Upgrade and Derivatives Surge

2026-06-27 17:03:56

Key Events This Week

22 Jun: Upgrade to Buy rating by MarketsMOJO

23 Jun: Stock price nears 52-week high at ₹6,784.95

25 Jun: Sharp 14.1% surge in open interest amid price decline

26 Jun: Week closes at ₹6,710.85 (-0.45%)

Week Open

Rs.6,741.15

Week Close

Rs.6,710.85

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Price Action

2026-06-25 15:00:35

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 14.1% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price decline of 0.62% on 25 Jun 2026, the stock’s derivatives market reveals a complex interplay of directional bets and liquidity dynamics that merit close attention from investors and analysts alike.

Read full news article

View All News